Xiang-Xu Wang

411 total citations
24 papers, 261 citations indexed

About

Xiang-Xu Wang is a scholar working on Oncology, Pulmonary and Respiratory Medicine and Molecular Biology. According to data from OpenAlex, Xiang-Xu Wang has authored 24 papers receiving a total of 261 indexed citations (citations by other indexed papers that have themselves been cited), including 13 papers in Oncology, 11 papers in Pulmonary and Respiratory Medicine and 9 papers in Molecular Biology. Recurrent topics in Xiang-Xu Wang's work include Ferroptosis and cancer prognosis (9 papers), Cancer Immunotherapy and Biomarkers (8 papers) and RNA modifications and cancer (5 papers). Xiang-Xu Wang is often cited by papers focused on Ferroptosis and cancer prognosis (9 papers), Cancer Immunotherapy and Biomarkers (8 papers) and RNA modifications and cancer (5 papers). Xiang-Xu Wang collaborates with scholars based in China and United States. Xiang-Xu Wang's co-authors include Hongmei Zhang, Yuqi Yang, Gang Hu, Tianwen Gao, Weinan Guo, Zhenjie Wu, Jianru Chen, Yangzi Tian, Ming Lu and Xiuli Yi and has published in prestigious journals such as Journal of Clinical Oncology, SHILAP Revista de lepidopterología and Journal of Hepatology.

In The Last Decade

Xiang-Xu Wang

22 papers receiving 260 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Xiang-Xu Wang China 10 136 99 94 61 40 24 261
Shuang Mo China 7 218 1.6× 96 1.0× 60 0.6× 81 1.3× 48 1.2× 7 312
Aditya S. Shirali United States 6 179 1.3× 68 0.7× 52 0.6× 48 0.8× 44 1.1× 9 300
Yu Xiong China 10 235 1.7× 115 1.2× 56 0.6× 60 1.0× 32 0.8× 34 360
Liguo Ye China 13 141 1.0× 114 1.2× 124 1.3× 54 0.9× 50 1.3× 27 331
Ling Gao China 10 160 1.2× 74 0.7× 40 0.4× 109 1.8× 32 0.8× 19 303
Shaoming Song China 9 99 0.7× 42 0.4× 88 0.9× 86 1.4× 37 0.9× 24 294
Ram C. Shankaraiah Italy 10 188 1.4× 147 1.5× 56 0.6× 95 1.6× 20 0.5× 11 339
Cailin Xue China 10 183 1.3× 143 1.4× 38 0.4× 32 0.5× 12 0.3× 18 309
Zijun Huo China 11 177 1.3× 65 0.7× 68 0.7× 52 0.9× 15 0.4× 26 350

Countries citing papers authored by Xiang-Xu Wang

Since Specialization
Citations

This map shows the geographic impact of Xiang-Xu Wang's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Xiang-Xu Wang with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Xiang-Xu Wang more than expected).

Fields of papers citing papers by Xiang-Xu Wang

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Xiang-Xu Wang. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Xiang-Xu Wang. The network helps show where Xiang-Xu Wang may publish in the future.

Co-authorship network of co-authors of Xiang-Xu Wang

This figure shows the co-authorship network connecting the top 25 collaborators of Xiang-Xu Wang. A scholar is included among the top collaborators of Xiang-Xu Wang based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Xiang-Xu Wang. Xiang-Xu Wang is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
3.
Song, Nanshan, et al.. (2024). Focusing on mitochondria in the brain: from biology to therapeutics. Translational Neurodegeneration. 13(1). 23–23. 31 indexed citations
4.
Ji, Hongchen, Lihong Wu, Xiang-Xu Wang, et al.. (2024). Stratifying hepatocellular carcinoma based on immunophenotypes for immunotherapy response and prognosis. SHILAP Revista de lepidopterología. 32(4). 200890–200890. 2 indexed citations
5.
Ji, Hongchen, Xiang-Xu Wang, Qiong Zhang, Chengkai Zhang, & Hongmei Zhang. (2024). Predicting TCR sequences for unseen antigen epitopes using structural and sequence features. Briefings in Bioinformatics. 25(3). 9 indexed citations
6.
Liu, Yunpeng, Xiaoshuang Zuo, Jianlin Wang, et al.. (2024). CXCL12+ tumor-associated endothelial cells promote immune resistance in hepatocellular carcinoma. Journal of Hepatology. 82(4). 634–648. 19 indexed citations
7.
Liu, Qingqing, et al.. (2024). The efficacy and safety of PD-1 inhibitor combined with TACE in the first-line treatment of unresectable hepatocellular carcinoma. Medical Oncology. 41(5). 91–91. 4 indexed citations
8.
Yang, Yuqi, Sijia Wang, Xiang-Xu Wang, et al.. (2024). Tumorous IRE1α facilitates CD8+T cells-dependent anti-tumor immunity and improves immunotherapy efficacy in melanoma. Cell Communication and Signaling. 22(1). 83–83. 5 indexed citations
9.
Wang, Xiang-Xu, et al.. (2023). 1935P Exploration of tertiary lymphatic structure in soft tissue sarcoma for the prognostic and immunotherapy response. Annals of Oncology. 34. S1039–S1040. 1 indexed citations
10.
Wang, Xiang-Xu, Lihong Wu, Qingqing Liu, et al.. (2023). Cuproptosis-Mediated Patterns Characterized by Distinct Tumor Microenvironment and Predicted the Immunotherapy Response for Gastric Cancer. ACS Omega. 8(12). 10851–10862. 10 indexed citations
11.
Lu, Yajie, Wei Pan, Xiang-Xu Wang, et al.. (2023). Redefining the Incidence and Profile of Fluoropyrimidine-Associated Cardiotoxicity in Cancer Patients: A Systematic Review and Meta-Analysis. Pharmaceuticals. 16(4). 510–510. 6 indexed citations
12.
Wu, Lihong, Xiang-Xu Wang, Yan Wang, et al.. (2023). Construction and validation of a prognosis signature based on the immune microenvironment in gastric cancer. Frontiers in Surgery. 10. 1088292–1088292.
14.
Wang, Xiang-Xu, et al.. (2022). Construction of m6A-based prognosis signature and prediction for immune and anti-angiogenic response. Frontiers in Molecular Biosciences. 9. 1034928–1034928. 13 indexed citations
15.
Wang, Xiang-Xu, Haiyan Cao, Min Chao, et al.. (2022). Immune Gene Signatures and Immunotypes in Immune Microenvironment Are Associated With Glioma Prognose. Frontiers in Immunology. 13. 823910–823910. 5 indexed citations
16.
Wang, Xiang-Xu, Lihong Wu, Hongchen Ji, et al.. (2022). A novel cuproptosis-related prognostic signature and potential value in HCC immunotherapy. Frontiers in Molecular Biosciences. 9. 1001788–1001788. 12 indexed citations
17.
Ji, Hongchen, Qiong Zhang, Xiang-Xu Wang, et al.. (2022). Identification of stromal microenvironment characteristics and key molecular mining in pancreatic cancer. Discover Oncology. 13(1). 83–83. 1 indexed citations
18.
Wang, Xiang-Xu, et al.. (2021). Construction of an HCC recurrence model based on the investigation of immune-related lncRNAs and related mechanisms. Molecular Therapy — Nucleic Acids. 26. 1387–1400. 10 indexed citations
19.
Wang, Xiang-Xu, et al.. (2020). Advances in Artificial Intelligence-assisted Diagnosis of Malignant Tumors. SHILAP Revista de lepidopterología. 2 indexed citations
20.
Meng, L., et al.. (2012). Neurotrophic Artemin Promotes Motility and Invasiveness of MIA PaCa-2 Pancreatic Cancer Cells. Asian Pacific Journal of Cancer Prevention. 13(5). 1793–1797. 10 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026